Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of Nasopharynx

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, YL; Ching, AS; Lee, SF; Leung, SF; Yeung, DK1

Trials

1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of Nasopharynx

ArticleYear
Dynamic susceptibility contrast-enhanced perfusion MR imaging in late radiation-induced injury of the brain.
    Acta neurochirurgica. Supplement, 2005, Volume: 95

    Topics: Adult; Aged; Brain; Brain Injuries; Cerebrovascular Circulation; Contrast Media; Female; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Radiation Dosage; Radiation Injuries; Radiotherapy; Temporal Lobe

2005